<DOC>
	<DOCNO>NCT00564148</DOCNO>
	<brief_summary>The study intend assess effect Avastin injection different proliferative retinopathy due different cause</brief_summary>
	<brief_title>Intravitreal Avastin Proliferative Retinopathies</brief_title>
	<detailed_description>Proliferative retinopathy due different cause represent important cause visual acuity loss . Conventional treatment may sometimes improve visual function , whereas time , visual acuity continue decrease , spite medical , surgical laser treatment . Intravitreal injection anti-VEGF agent ( ex . Avastin trial ) seem important tool certain difficult situation ocular fundus , different reason ( advanced age , diabetes mellitus , retinal vein occlusion , etc ) new pathologic vessel appear , cause devastate change posterior anterior segment well .</detailed_description>
	<mesh_term>Neovascularization , Pathologic</mesh_term>
	<mesh_term>Retinal Neovascularization</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>clinical diagnosis proliferative retinopathy ( AGE RELATED MACULAR DEGENERATION , DIABETIC PROLIFERATIVE RETINOPATHY , etc ) distance acuity &lt; 0.5 age &gt; 20 year noncooperative patient ocular infection / inflammation</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>antiVEGF therapy</keyword>
</DOC>